Transcat reported Q1 FY2026 results with 14.6% revenue growth to $76.4 million, beating EPS estimates but experiencing margin pressures in its service segment. The company continues its acquisition strategy and focuses on software innovation in calibration services.

Transcat, Inc. (NASDAQ:TRNS) reported better-than-expected fourth-quarter financial results, after the closing bell on Monday. Transcat posted adjusted earnings of 66 cents per share, beating market estimates of 53 cents per share. The company's quarterly sales came in at $70.913 million versus expectations of $68.595 million, according to data from Benzinga Pro. “We are extremely pleased with our fourth quarter and full year fiscal 2024 results as double-digit organic Service revenue growth and increased productivity drove Service gross margin expansion while Distribution gross margins soared due to growth in Rentals,” commented Lee D. Rudow, President and CEO. “Adjusted EBITDA growth of 30% for the fourth quarter ...Full story available on Benzinga.com

4 analysts have expressed a variety of opinions on Transcat (NASDAQ:TRNS) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 1 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 1 0 0 0 3M Ago 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $141.25, along with a high estimate of $160.00 and a low estimate of $124.00. Observing a 14.84% increase, the current average has risen from the previous average price target of $123.00. Investigating Analyst Ratings: An Elaborate Study An in-depth analysis of recent analyst actions unveils how financial experts perceive Transcat. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Martin Yang Oppenheimer Raises Outperform $160.00 $125.00 Scott Buck HC Wainwright & Co. Raises Buy $156.00 $124.00 Martin Yang Oppenheimer Raises Outperform $125.00 $120.00 Scott Buck HC Wainwright & Co. Maintains Buy $124.00 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Transcat. This insight gives a snapshot of analysts' perspectives on the current state of the company. Rating: Providing ...Full story available on Benzinga.com

The testing equipment company exceeded expectations and sees further growth up ahead

The headline numbers for Transcat (TRNS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Transcat (TRNS) delivered earnings and revenue surprises of 48.08% and 3.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Transcat (TRNS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

Transcat (TRNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

While the top- and bottom-line numbers for Transcat, Inc. (TRNS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Transcat, Inc. (TRNS) delivered earnings and revenue surprises of 8.57% and 2.85%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Badger Meter (BMI) delivered earnings and revenue surprises of 5% and 0.96%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Evaluate the expected performance of Transcat, Inc. (TRNS) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.